Onward Medical N.V. (ONWRF)
OTCMKTS · Delayed Price · Currency is USD
5.05
-0.55 (-9.82%)
At close: Feb 2, 2026
Onward Medical Revenue
Onward Medical had revenue of 1.19M EUR in the half year ending June 30, 2025, with 27.69% growth. This brings the company's revenue in the last twelve months to 2.72M. In the year 2024, Onward Medical had annual revenue of 1.74M with 226.88% growth.
Revenue (ttm)
2.72M EUR
Revenue Growth
+226.88%
P/S Ratio
69.65
Revenue / Employee
26.48K EUR
Employees
103
Market Cap
222.16M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.74M | 1.21M | 226.88% |
| Dec 31, 2023 | 532.00K | -1.62M | -75.23% |
| Dec 31, 2022 | 2.15M | 749.00K | 53.54% |
| Dec 31, 2021 | 1.40M | 599.00K | 74.88% |
| Dec 31, 2020 | 800.00K | 246.00K | 44.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| South Dakota Soybean Processors, LLC | 484.17M |
| Pacific Oak Strategic Opportunity REIT | 88.79M |
| Scope Industries | 77.00M |
| First Northern Community Bancorp | 72.01M |
| Muncy Columbia Financial | 70.12M |
| First Farmers and Merchants | 66.95M |
| Malaga Financial | 45.90M |
| Silence Therapeutics | 25.83M |
Onward Medical News
- 2 months ago - Onward Medical N.V. (ONWRF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Onward Medical N.V. (ONWRF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 10 months ago - ONWARD Medical Announces Release of 2024 Annual Report - GlobeNewsWire
- 10 months ago - ONWARD Medical Establishes US ADR Program and Begins Trading on OTCQX Best Market - GlobeNewsWire
- 11 months ago - ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights - GlobeNewsWire
- 11 months ago - ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility - GlobeNewsWire
- 11 months ago - ONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast - GlobeNewsWire
- 1 year ago - ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy - GlobeNewsWire